Oncology News

The addition of nab-paclitaxel to cisplatin-based concurrent chemoradiotherapy appeared effective for women with locally advanced cervical cancer, according to prospective study results.

Prenatal exposure in the 1960s and ’70s to dicyclomine, a component of the anti-nausea drug Bendectin, increased the risk for colorectal cancer in adult offspring, according to data reported in JNCI Cancer Spectrum.

Current or recent use of progestogen-only contraceptives was associated with a “slight” increase in breast cancer risk, according to findings from a nested case-control study and meta-analysis published in PLOS Medicine.

Mailing HPV self-sampling kits to women who are overdue for cervical cancer screening was cost-effective in increasing screening uptake compared with usual care, according to an economic evaluation published in JAMA Network Open.

For medicine to advance, entrenched paradigms must yield to new evidence. The widely held belief that menopausal hormone therapy causes breast cancer, and thus should never be given to breast cancer survivors, must be reassessed.

More than ever before, women today may have more information — and misinformation — about menopause.

Insurance status substantially mediated racial and ethnic inequities among women with advanced-stage cervical cancer, researchers reported in JAMA Network Open.

The FDA updated mammography regulations to require facilities to inform patients about their breast density, improve oversight and enforcement of facilities and aid physicians to better categorize and assess mammograms.

Women who were diagnosed with thyroid cancer as adolescents or young adults have no difference in pregnancy rates compared with those who have never had thyroid cancer, according to a study published in Thyroid.

The FDA is aware of 19 cases of squamous cell carcinoma in scar tissue that forms around breast implants, the agency announced today in a safety communication.